221 – 230 of 342
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Montelukast in the treatment of asthma and beyond
(
- Contribution to journal › Scientific review
-
Mark
The levels of cysteinyl-leukotrienes in exhaled breath condensate cannot be explained by saliva contamination
2009) 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology In Allergy 64. p.253-253(
- Contribution to journal › Published meeting abstract
-
Mark
Swimmers have evidence of epithelial dysfunction measured as increased urinary concentration of Clara cell protein (CC16) after swimming
2009) 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology In Allergy 64. p.33-33(
- Contribution to journal › Published meeting abstract
-
Mark
Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis.
(
- Contribution to journal › Article
-
Mark
Novel Site-Specific Mast Cell Subpopulations in the Human Lung.
(
- Contribution to journal › Article
- 2008
-
Mark
Evaluating combination therapies for asthma: pros, cons and comparative benefits
(
- Contribution to journal › Scientific review
-
Mark
Airway inflammation: An important marker of control for asthma guidelines? Reply
(
- Contribution to journal › Letter
-
Mark
Methods used in clinical development of novel anti-asthma therapies
(
- Contribution to journal › Scientific review
-
Mark
Allergic rhinitis with hyper-responsiveness differ from asthma in degree of peripheral obstruction during metacholine challenge test.
(
- Contribution to journal › Article
-
Mark
Allergy: a systemic disease? The HUNT and Young-HUNT study, Norway.
(
- Contribution to journal › Article